Editorial Board

Editorial Board

Section Editor
Mary J Laughlin, Division of Hematology/Oncology, University of Virginia, USA
Alejandro Lazo-Langner, University of Western Ontario, Canada

Associate Editors
Hematopoiesis and stem cells
 
William Hwang, Singapore General Hospital and Duke-NUS Medical School, Singapore
Cheng-Kui Qu, Emory University, USA
Linda Scott, University of Queensland, Australia

Hemostasis, thrombosis and vascular biology
Eduardo Angles-Cano, Inserm, France
Raul A De La Cadena, Temple University School of Medicine, USA
Anthony E Dear, Monash University, Australia
Ana-Rebeca Jaloma-Cruz, Centro de Investigacion Biomedica de Occidente, Mexico
Johnny N Mahlangu, Charlotte Maxeke Johannesburg Academic Hospital, South Africa
Alessandro Squizzato, University of Insubria, Italy

Malignant hematological diseases
John Byrd, Ohio State University, Medical College, USA
Jorge Cortes, MD Anderson Cancer Center, USA
Jerry L Spivak, Johns Hopkins University School of Medicine, USA
Wyndham H Wilson, National Cancer Institute, USA
Emanuele Zucca, Oncology Institute of Southern Switzerland, Switzerland

Non-malignant hematological diseases
Omar S Aljitawi, University of Kansas Medical Center, USA
Philippe Connes, Inserm, Guadeloupe
James Taylor, NHLBI, USA
Binglan Yu, Massachusetts General Hospital, USA
Alauldeen Zubair Al-Mustansiriya, University-College of Medicine, Iraq

Editorial Advisors
Peter Browett, University of Auckland, New Zealand
Inderjeet Dokal, Imperial College, UK
Connie J Eaves, British Columbia Cancer Agency, Canada
Kenneth Mann, University of Vermont, USA
Alan Schechter, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, USA
John F Seymour, Peter MacCallum Cancer Centre, Australia
Jeff Szer, Royal Melbourne Hospital, Australia Jeffrey Weitz McMaster University, Canada

Statistical Advisors
Kristen Stevenson, Dana-Farber/Harvard Cancer Center, USA